NOACs match warfarin for atrial fibrillation
Real-world study data from Denmark show that non-vitamin K antagonist oral anticoagulants are effective alternatives to warfarin in patients with non-valvular atrial fibrillation in a routine care setting. (Source: MedWire News)
Source: MedWire News - June 23, 2016 Category: Consumer Health News Tags: Cardiology Source Type: news

NOACs: Polypharmacy, Renal Impairment, Real-World Use
(MedPage Today) -- Studies show consistency of effect relative to warfarin (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 22, 2016 Category: Cardiology Source Type: news

Drug safety update: Topical miconazole interactions with warfarin
Drug safety update: Topical miconazole, including oral gel: reminder of potential for serious interactions with warfarin The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 21, 2016 Category: Drugs & Pharmacology Source Type: news

Apixaban effective in polypharmacy setting
The superiority of apixaban over warfarin in patients with atrial fibrillation is maintained in those taking multiple medications, shows further analysis of the ARISTOTLE trial. (Source: MedWire News)
Source: MedWire News - June 21, 2016 Category: Consumer Health News Tags: Arrhythmia Source Type: news

Novel Oral Anticoagulants Safe Alternatives to Warfarin in Atrial Fibrillation (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH Non-vitamin K antagonist oral anticoagulants are generally safer and more effective than warfarin in clinical practice, … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 20, 2016 Category: Primary Care Source Type: news

Predicting Adverse Events With Dabigatran or Warfarin in AFPredicting Adverse Events With Dabigatran or Warfarin in AF
This study examined various models that aim to quantify expected rates of thromboembolism and major bleeding for a given patient if that patient were to initiate treatment with dabigatran or warfarin British Medical Journal (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 10, 2016 Category: Intensive Care Tags: Internal Medicine Journal Article Source Type: news

FDA releases May 2016 510(k) clearances
510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD May 2016 TOTAL 510(k)s THIS PERIOD 213 TOTAL WITH SUMMARIES 205 TOTAL WITH STATEMENTS 8 May 2016 510(k) Clearances SHARE TWEET LINKEDIN PIN IT EMAIL PRINT 510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD May 2016 DEVICE: O-PEP PARI RESPIRATORY EQUIPMENT, INC. 510(k) NO: K150044(Traditional) ATTN: Michael Judge PHONE NO : 1 804 2537274 2412 PARI Way SE DECISION MADE: 27-MAY-16 Midlothian VA 23112 510(k) SUMMARY AVAILABLE FROM FDA ...
Source: Mass Device - June 8, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

Valvular AF With HF Common, Often Untreated in Young Africans Valvular AF With HF Common, Often Untreated in Young Africans
Other issues in sub-Saharan Africa: access can be limited and follow-ups less likely, making it tough to monitor warfarin; yet the NOACs tend to be prohibitively expensive, caution researchers. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 7, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

NOACs Best Warfarin in Mortality Meta-analysisNOACs Best Warfarin in Mortality Meta-analysis
Dr Goldhaber comments on a study that shows a lower risk for early mortality in patients who took NOACs compared with those who took warfarin. theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 27, 2016 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Use of newer oral anticoagulants in AF
A guide to using novel oral anticoagulants (NOACs) for stroke prevention in non-valvular atrial fibrillation, including the safety and efficacy profiles of newer anticoagulants and how to switch patients from warfarin to NOACs. (Source: GP Online Education)
Source: GP Online Education - May 24, 2016 Category: Primary Care Tags: 15.1 Cardiovascular Problems Source Type: news

Warfarin 'Dangerous' After Bioprosthetic Valves?
(MedPage Today) -- Bleeding risk, no benefit found in SAVR meta-analysis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 11, 2016 Category: Cardiology Source Type: news

Common drug used to treat an irregular heart beat 'increases the risk of Alzheimer's', experts warn
Scientists in Utah found patients diagnosed with atrial fibrillation and prescribed the blood thinner, Warfarin are more likely to develop dementia, Alzheimer's disease and vascular dementia. (Source: the Mail online | Health)
Source: the Mail online | Health - May 10, 2016 Category: Consumer Health News Source Type: news

NOAC prescribing varies 16-fold between CCG areas
The proportion of AF patients at high risk of stroke who are receiving anticoagulation with NOACs instead of warfarin varies 16-fold across England, a report suggests. (Source: GP Online News)
Source: GP Online News - May 9, 2016 Category: Primary Care Tags: 15.1 Cardiovascular Problems Source Type: news

Warfarin Cuts Afib Stroke Risk Down to Normal (CME/CE)
(MedPage Today) -- Residual stroke risk similar to that of non-afib population (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 6, 2016 Category: Cardiology Source Type: news

Atrial fibrillation and poor management of warfarin may increase risk of dementia
Research was presented today, Thursday 05 May, at Heart Rhythm 2016 conference. (Source: Alzheimers Society)
Source: Alzheimers Society - May 6, 2016 Category: Geriatrics Source Type: news

Widely Used Heart Drug Tied to Dementia Risk
Both warfarin and the atrial fibrillation it's often used to treat may raise risk, study suggests (Source: WebMD Health)
Source: WebMD Health - May 5, 2016 Category: Consumer Health News Source Type: news

Widely Used Heart Drug Tied to Dementia Risk
Both warfarin and the atrial fibrillation it's often used to treat may raise risk, study suggests Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Blood Thinners, Dementia (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 5, 2016 Category: Consumer Health News Source Type: news

Warfarin, AF May Each Contribute to Dementia Risk in AFWarfarin, AF May Each Contribute to Dementia Risk in AF
Anticoagulation clearly plays a role in long-term brain health, a researcher notes, but "we learned as well that atrial fibrillation is an additive disease state, in that it increases risk beyond anticoagulation." Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 5, 2016 Category: Consumer Health News Tags: Cardiology News Source Type: news

Atrial fibrillation patients treated with warfarin have higher rates of dementia, new study finds
Study of more than 10,000 patients treated long term with the blood thinner, warfarin, reveals higher rates of dementia for patients with atrial fibrillation versus non-AF patients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 5, 2016 Category: Science Source Type: news

Medical News Today: Warfarin use for atrial fibrillation increases dementia risk
A new study using data from more than 10,000 patients demonstrates a link between warfarin, atrial fibrillation, and an increased risk of dementia. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 5, 2016 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

Apr 29 Cardiology NewsApr 29 Cardiology News
ECG screening in athletes, warfarin for AF, sugar-sweetened beverages, CT-induced cancer treatment costs, and night-shift work are the topics discussed by John Mandrola in this week’s podcast. theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 29, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

'Well-Managed Warfarin' Good Enough in Atrial Fib: Analysis'Well-Managed Warfarin' Good Enough in Atrial Fib: Analysis
Reopening the warfarin-vs-NOAC debate in atrial fibrillation, low complication rates on the older drug in a Swedish national cohort study impressed, but are they generalizable? Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 23, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

Study: Warfarin Still a Good Option for Afib Stroke Prevention (CME/CE)
(MedPage Today) -- But others warn against using these Swedish registry data to guide tx (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 21, 2016 Category: Cardiology Source Type: news

Warfarin Can Be Safe, Effective for People With Irregular Heartbeat
Title: Warfarin Can Be Safe, Effective for People With Irregular HeartbeatCategory: Health NewsCreated: 4/20/2016 12:00:00 AMLast Editorial Review: 4/21/2016 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - April 21, 2016 Category: Cardiology Source Type: news

Warfarin and People With an Irregular Heartbeat
Study supports well-managed use of the cheap, standby drug, but one expert prefers newer blood thinners (Source: WebMD Health)
Source: WebMD Health - April 21, 2016 Category: Consumer Health News Source Type: news

Warfarin Can Be Safe, Effective for People With Irregular Heartbeat
WEDNESDAY, April 20, 2016 -- Millions of American heart patients take warfarin -- for decades a cheap, but often tricky-to-manage mainstay blood thinner. Now, new research shows that when it is well-managed, warfarin treatment appears safe for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 20, 2016 Category: Journals (General) Source Type: news

Well-managed warfarin therapy associated with low risk of complications in patients with atrial fibrillation
The efficacy and safety of well-managed warfarin therapy in patients with nonvalvular atrial fibrillation has been the focus of recent study. Atrial fibrillation is a strong independent risk factor for ischemic stroke. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 20, 2016 Category: Science Source Type: news

New Data Reaffirm Positive Benefit-Risk Balance of Bayer’s Xarelto® in Patients with Atrial Fibrillation in Daily Clinical Practice (for specialized target groups only)
Insights from nearly 23,000 patients with atrial fibrillation on the prevention of stroke and incidence of intracranial haemorrhage with Xarelto vs. warfarin / Results confirm the efficacy and safety profile of Xarelto as determined in pivotal Phase III ROCKET AF and other real-world studies (Source: Bayer Company News)
Source: Bayer Company News - April 18, 2016 Category: Pharmaceuticals Source Type: news

Poor patient warfarin knowledge may increase risk of deadly side effects
Patients have poor knowledge of warfarin which may increase their risk of serious side effects, according to research. Warfarin is given to patients at increased risk of blood clots from conditions such as atrial fibrillation or a mechanical heart valve. It 'thins the blood' by slowing down the anticoagulation effect of vitamin K, thereby increasing the time it takes blood to clot and reducing the risk of stroke. Taking too much warfain raises the risk of bleeding. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 15, 2016 Category: Science Source Type: news

Newer blood thinning drugs safer for reducing atrial fibrillation
Stephen FellerWASHINGTON, April 13 (UPI) -- Researchers at Loyola University found newer blood thinning drugs are effective as warfarin at thinning blood to reduce stroke risk but require less monitoring. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 13, 2016 Category: Consumer Health News Source Type: news

POISON PRESCRIPTION: Warfarin rat poison widely used as prescription blood thinner
(NaturalNews) Many drugs pushed out by Big Pharma are equivalent to rat poison, but only a handful can actually claim to be rat poison. Meet warfarin: a widely used blood thinner which, prior to being used to treat a common heart rhythm disorder called atrial fibrillation, was used... (Source: NaturalNews.com)
Source: NaturalNews.com - April 4, 2016 Category: Consumer Health News Source Type: news

Edoxaban vs Warfarin in Patients With Nonvalvular AFEdoxaban vs Warfarin in Patients With Nonvalvular AF
This study compared 2 dosing regimens of edoxaban, a direct factor Xa inhibitor, with warfarin in patients with non-valvular AF. American Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 31, 2016 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

NOACs No Better Than Warfarin Against Thrombi in Afib (CME/CE)
(MedPage Today) -- Apixaban might be exception, but study lacked power to confirm (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 26, 2016 Category: Cardiology Source Type: news

Rivaroxaban Saves Hospitals Money for VTE Admissions: StudyRivaroxaban Saves Hospitals Money for VTE Admissions: Study
U.S. hospitals save money when they use the novel oral anticoagulant rivaroxaban instead of warfarin to treat patients with venous thromboembolism (VTE), a new analysis finds. Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 22, 2016 Category: Surgery Tags: Internal Medicine News Source Type: news

FDA weighs dangers of faulty readings from blood clot monitors
The FDA is considering possible dangers from medical devices that monitor blood clotting producing false readings, according to a report from The Wall Street Journal. The FDA has tracked thousands of cases of malfunctions from such devices over the years, the WSJ reports. Deaths and serious injuries have been linked with the erroneous readings, due to the increased susceptibility of individuals on anticoagulant drugs to strokes and other dangerous events. The federal watchdog brought together a panel of experts to discuss “point of care” clotting monitors last Friday to try and analyze the extent of the problem...
Source: Mass Device - March 21, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance Alere Source Type: news

Warfarin, Not Aspirin, May Aid Asian AF Patients With Prior ICHWarfarin, Not Aspirin, May Aid Asian AF Patients With Prior ICH
"We really need more data for this patient population," an expert says, particularly now that there are more options, including different NOACs and Watchman. Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 21, 2016 Category: Consumer Health News Tags: Cardiology News Source Type: news

Webcast Archive and Presentations posted for Public Workshop - Point of Care Prothrombin Time/International Normalized Ratio Devices for Monitoring Warfarin Therapy, March 18, 2016
The Food and Drug Administration (FDA) announced the following public workshop entitled “Point of Care Prothrombin Time/International Normalized Ratio Devices for Monitoring Warfarin Therapy.” The purpose of this workshop was to discuss and receive... (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - March 21, 2016 Category: Medical Equipment Source Type: news

Accuracy Concerns on Testing Device for Blood-Thinning Drug
Thousands of reports say a device to measure the levels of warfarin with a drop of blood is malfunctioning, yet it remains on the market. (Source: NYT Health)
Source: NYT Health - March 18, 2016 Category: Consumer Health News Authors: KATIE THOMAS Tags: Drugs (Pharmaceuticals) Medical Devices Tests (Medical) HemoSense Incorporated Source Type: news

Warfarin Tx May Need Second Look in Seniors With Afib (CME/CE)
(MedPage Today) -- Study in vets finds unique risk factors for traumatic intracranial bleeding (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 10, 2016 Category: Cardiology Source Type: news

Warfarin Brain Bleed Risk: Higher Than Thought?
Study of veterans with irregular heartbeat found one-third suffered such incidents while on the drug (Source: WebMD Health)
Source: WebMD Health - March 9, 2016 Category: Consumer Health News Source Type: news

Brain bleed risk from warfarin may be higher than thought
HeathDay News The widely used blood thinner warfarin, sold as Coumadin, may raise the risk of severe bleeding inside the skull by much more than previously thought. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 9, 2016 Category: Consumer Health News Source Type: news

Brain Bleed Risk from Warfarin May Be Higher Than Thought
Study of veterans with irregular heartbeat found one-third suffered such incidents while on the drug Source: HealthDay Related MedlinePlus Pages: Blood Thinners, Drug Reactions (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 9, 2016 Category: Consumer Health News Source Type: news

Brain Bleed Risk From Warfarin May Be Higher Than Thought
Study of veterans with irregular heartbeat found one-third suffered such incidents while on the drug (Source: U.S. News - Health)
Source: U.S. News - Health - March 9, 2016 Category: Consumer Health News Source Type: news

Brain Bleed Risk From Warfarin May Be Higher Than Thought
WEDNESDAY, March 9, 2016 -- The widely used blood thinner warfarin -- also known as Coumadin -- may raise the risk of severe bleeding inside the skull by much more than previously thought, a new study suggests. Researchers examined data from nearly... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 9, 2016 Category: Journals (General) Source Type: news

A New Life for Warfarin Clinics in the NOAC Era?
(MedPage Today) -- Gordon Tomaselli, MD, talks feasibility and cost of repurposing (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 4, 2016 Category: Cardiology Source Type: news

Weight-Based Prothrombin Stops Warfarin-Induced BleedingWeight-Based Prothrombin Stops Warfarin-Induced Bleeding
Warfarin-induced coagulopathy can be reversed faster with a weight-based factor VIII inhibitor bypassing activity regimen than with fresh frozen plasma, researchers report, but mortality is similar. Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 3, 2016 Category: Surgery Tags: Critical Care News Source Type: news

Warfarin after ICH reduces Danish hospitalisation costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - March 1, 2016 Category: Drugs & Pharmacology Source Type: news

VIDEO: Intracranial warfarin bleeds smaller with prothrombin complex instead of FFP
LOS ANGELES – The international normalized ratio fell to 1.2 or less within 3 hours among 18 of 27 (67%) patients who received four-factor prothrombin complex concentrate (octaplex [Octapharma]) for... (Source: Clinical Neurology News)
Source: Clinical Neurology News - February 29, 2016 Category: Neurology Source Type: news